Published in Oncotarget on September 22, 2015
Comparison of Prognostic MicroRNA Biomarkers in Blood and Tissues for Gastric Cancer. J Cancer (2016) 0.82
The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism. Sci Rep (2016) 0.79
MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia. J Cancer Res Clin Oncol (2016) 0.77
Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network. Oncotarget (2016) 0.76
SLC7A5 act as a potential leukemic transformation target gene in myelodysplastic syndrome. Oncotarget (2016) 0.76
High level of miR-196b at newly diagnosed pediatric acute myeloid leukemia predicts a poor outcome. EXCLI J (2017) 0.75
Novel Biomarker MicroRNAs for Subtyping of Acute Coronary Syndrome: A Bioinformatics Approach. Biomed Res Int (2016) 0.75
Knowledge-Guided Bioinformatics Model for Identifying Autism Spectrum Disorder Diagnostic MicroRNA Biomarkers. Sci Rep (2016) 0.75
Network Biomarkers Constructed from Gene Expression and Protein-Protein Interaction Data for Accurate Prediction of Leukemia. J Cancer (2017) 0.75
Biological Networks for Cancer Candidate Biomarkers Discovery. Cancer Inform (2016) 0.75
MicroRNA-mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients. Front Pharmacol (2016) 0.75
Diagnostic MicroRNA Biomarker Discovery for Non-Small-Cell Lung Cancer Adenocarcinoma by Integrative Bioinformatics Analysis. Biomed Res Int (2017) 0.75
The hallmarks of cancer. Cell (2000) 113.05
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16
Requirement of bic/microRNA-155 for normal immune function. Science (2007) 16.24
Regulation of the germinal center response by microRNA-155. Science (2007) 12.25
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A (2006) 10.65
Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med (2008) 5.97
MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood (2008) 5.23
MicroRNAs in cancer. Annu Rev Pathol (2009) 4.47
Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol (2011) 4.34
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A (2008) 4.26
CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A (2007) 4.06
microRNAs and the immune response. Trends Immunol (2008) 3.63
MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood (2008) 3.50
Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res (2009) 3.44
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci U S A (2008) 3.13
MicroRNAs: regulators of gene expression and cell differentiation. Blood (2006) 3.08
Chromosome cohesion, condensation, and separation. Annu Rev Biochem (2000) 2.69
MicroRNAs and cell cycle regulation. Cell Cycle (2007) 2.62
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood (2012) 2.39
The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology (2009) 2.35
Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One (2008) 2.27
Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood (2009) 2.26
Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms. Nat Genet (2013) 2.14
Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood (2009) 2.11
MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev (2011) 1.60
Differential expression of specific microRNA and their targets in acute myeloid leukemia. Am J Hematol (2010) 1.51
miRNA expression profiling of lung adenocarcinomas: correlation with mutational status. Mod Pathol (2010) 1.46
Pediatric acute myeloid leukemia: international progress and future directions. Leukemia (2005) 1.37
MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer. Oncol Rep (2011) 1.34
MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells Mol Dis (2010) 1.26
GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia. Blood (2012) 1.22
Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia. Blood (1999) 1.18
Integrative network analysis reveals active microRNAs and their functions in gastric cancer. BMC Syst Biol (2011) 1.17
miR-92a family and their target genes in tumorigenesis and metastasis. Exp Cell Res (2014) 1.13
Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformation. Cancer Discov (2013) 1.13
Comprehensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression. Nucleic Acids Res (2013) 1.11
MicroRNA-21 as a potential colon and rectal cancer biomarker. World J Gastroenterol (2013) 1.10
Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer. J Transl Med (2014) 1.10
Transcription factor-microRNA-target gene networks associated with ovarian cancer survival and recurrence. PLoS One (2013) 1.06
Clear cell renal cell carcinoma associated microRNA expression signatures identified by an integrated bioinformatics analysis. J Transl Med (2013) 1.05
The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia. Cell Death Differ (2013) 1.03
MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia. Leuk Res (2011) 1.02
MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia. Leukemia (2013) 0.96
Transcription factor and microRNA co-regulatory loops: important regulatory motifs in biological processes and diseases. Brief Bioinform (2013) 0.94
Identification of microRNA as sepsis biomarker based on miRNAs regulatory network analysis. Biomed Res Int (2014) 0.92
MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways. PLoS One (2013) 0.90
Novel therapies for children with acute myeloid leukaemia. Leukemia (2013) 0.88
Detecting microRNAs of high influence on protein functional interaction networks: a prostate cancer case study. BMC Syst Biol (2012) 0.86
Preferential loss of mismatch repair function in refractory and relapsed acute myeloid leukemia: potential contribution to AML progression. Cell Res (2008) 0.83
Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison. Sci Rep (2016) 0.77
Network Biomarkers Constructed from Gene Expression and Protein-Protein Interaction Data for Accurate Prediction of Leukemia. J Cancer (2017) 0.75
Knowledge-Guided Bioinformatics Model for Identifying Autism Spectrum Disorder Diagnostic MicroRNA Biomarkers. Sci Rep (2016) 0.75